Plocabulin a novel tubulin-binding agent inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells

摘要

BackgroundVascular supply of tumors is one of the main targets for cancer therapy. Here, we investigated if plocabulin (PM060184), a novel marine-derived microtubule-binding agent, presents antiangiogenic and vascular-disrupting activities.